浏览全部资源
扫码关注微信
1. 江西省宜春市第三人民医院精神科
2. 宜春市医药协会办公室
纸质出版日期:2010
移动端阅览
熊典樟, 刘灵灵, 易燕, 等. 电针联合小剂量氯氮平治疗难治性精神分裂症的疗效观察[J]. 针刺研究, 2010,35(2):134-137.
XIONG Dian-zhang, LIU Ling-ling1, YI-Yan, et al. Observation on the Therapeutic Effect of Electroacupuncture Combined with Small Dose of Clozapine in Clinical Treatment of Refractory Schizophrenia[J]. Acupuncture research, 2010, 35(2): 134-137.
熊典樟, 刘灵灵, 易燕, 等. 电针联合小剂量氯氮平治疗难治性精神分裂症的疗效观察[J]. 针刺研究, 2010,35(2):134-137. DOI: 10.13702/j.1000-0607.2010.02.016.
XIONG Dian-zhang, LIU Ling-ling1, YI-Yan, et al. Observation on the Therapeutic Effect of Electroacupuncture Combined with Small Dose of Clozapine in Clinical Treatment of Refractory Schizophrenia[J]. Acupuncture research, 2010, 35(2): 134-137. DOI: 10.13702/j.1000-0607.2010.02.016.
目的:评价电针联合小剂量氯氮平治疗难治性精神分裂症的有效性和安全性。方法:将难治性精神分裂症患者随机分为西药组和针药结合组各40例。西药组患者均采用口服氯氮平治疗;针药结合组患者选百会及太阳穴电针治疗
同时口服小剂量氯氮平。比较两组患者治疗前后阳性与阴性症状量表(PAN-SS)、副反应量表(TESS)评分及临床疗效。结果:两组治疗后PANSS均下降
且两组比较差异无统计学意义(P>0.05)。治疗后针药结合组TESS评分结果显著低于西药组(P<0.01)。西药组愈显率35.0%(14/40)
有效率77.5%(31/40)
针药结合组愈显率32.5%(13/40)
有效率72.5%(29/40)
两组比较差异无统计学意义(P>0.05)。结论:两组方法治疗难治性精神分裂症疗效相当
而针药结合组不良反应更轻
提示电针配合小剂量氯氮平是治疗难治性精神分裂症的较好方法。
Objective To observe the effect of electroacupuncture(EA) in combination with small dose of clozapine on clinical symptoms of refractory schizophrenia patients so as to evaluate its validity and security.Methods Eighty schizophrenia patients were randomized into medication group and EA+medication group(n=40/group).Patients of medication group were treated with conventional oral administration of clozapine(50-100 mg/d to 200-500 mg/d
for 8 weeks) and those of EA+ medication group treated by EA of Baihui(GV 20) and bilateral Taiyang(EX-HN 5) and oral administration of clozapine(50 mg/d to 100-150 mg/d).EA was given to the patients
3 times a week for 8 weeks.Scores of the Positive and Negative Symptom Scale(PANSS) and the Untoward Effect Symptom Scale(TESS) were used to assess the therapeutic effect.Results Following treatment
PANSS scores for positive symptoms and the common psychiatric symptoms of the medication and EA+medication groups all decreased evidently from the 2rd week on(P<0.05
P<0.01)
and those of the negative symptoms reduced obviously from the 4th week on(P<0.05).Comparison between two groups showed no significant differences in PANSS scores for positive and negative symptoms and the common psychiatric symptoms after the treatment(P>0.05).But TESS score of EA+medication group was evidently lower than that of medication group(P<0.01)
suggesting an apparently fewer untoward effects in EA+medication group.Of the two 40 cases in medication and EA+medication groups
6(15%) and 5(12.5%) were cured
8 and 8(20%) experienced marked improvement in their symptoms
17(42.5%) and 16(40%) had an improvement
9(22.5%) and 11(27.5%) failed
with the effective rates being 77.5% and 72.5% separately.Conclusion Both medication and EA+medication can improve refractory schizophrenia patients'clinical symptoms
but the later has fewer untoward effects.
0
浏览量
163
下载量
3
CNKI被引量
关联资源
相关文章
相关作者
相关机构